MedTech & Diagnostics Analysts Matson & Belanger, along with plastic surgeon Dr. Ross Stutman, plastic surgery and aesthetics including: breast implants, body sculpting, RF microneedling and GLP-1s (relevant companies ABBV APYX SKIN ESTA EOLS INMD) on an Analyst/Industry conference call to be held on October 16 at 1 pm.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie price target raised to $250 from $245 at Cantor Fitzgerald
- Aldeyra price target raised to $7 from $6 at Jefferies
- AbbVie reports ‘positive’ results from Phase 2 ELATE trial
- Wells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
- Looking for Exposure to UnitedHealth Stock (UNH)? Here’s How to Buy Without the Risk